Bleocip is a glycopeptide antibiotic produced by the bacterium Streptomyces verticillus. Bleocip refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily Bleocip A2 and B2. Bleocip A2 is shown in the image. The drug is used in the treatment of Hodgkin lymphoma (as a componen